Bispecific Antibody Ivonescimab Added to Chemotherapy in <i>EGFR</i> -Variant Non–Small Cell Lung Cancer

Unknown, Wenfeng Fang, Yuanyuan Zhao, Yongzhong Luo, Runxiang Yang, Yan Huang, Zhiyong He, Hui Zhao, Mingjun Li, Kai Li, Qibin Song, Xiaobo Du, Yulan Sun, Wei Li, Longhua Sun, Zhiyu Wang, Kunning Yang, Yun Fan, Baogang Liu, Hongyun Zhao, Ying Hu, Li Jia, Shen Xu, Tienan Yi, Dongqing Lv, Haitao Lan, Mengxia Li, Wenhua Liang, Yongsheng Wang, Hui Yang, Yuming Jia, Yuan Chen, Junguo Lu, Meiqi Shi, Chunling Liu, Ming Zhou, Jianya Zhou, Xianling Liu, Ningning Zhou, Ming He, Xiaorong Dong, Hualin Chen, Yongxing Chen, Haichuan Su, Xiaoling Li, Zhihong Zhang, Lei Yang, Ying Liu, Likun Chen, Xue Hou, Yu Zhang, Jun Guo, Ruiqiang Ma, Hong Lu, Di Wu, Weineng Feng, Wen Li, Jianan Huang, Yan Wang, Xia Song, Jiewen Peng, Laiyu Liu, Yubiao Guo, Wenting Li, Mengying Xia, Dongmei Lu, Mingxiu Hu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Y. Xia, Li Zhang

Open source

DOI
10.1001/jama.2026.7745
Published
2026-07-28
Container
JAMA
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jama.2026.7745,
  title = {Bispecific Antibody Ivonescimab Added to Chemotherapy in
                    <i>EGFR</i>
                    -Variant Non–Small Cell Lung Cancer},
  author = {Unknown and Wenfeng Fang and Yuanyuan Zhao and Yongzhong Luo and Runxiang Yang and Yan Huang and Zhiyong He and Hui Zhao and Mingjun Li and Kai Li and Qibin Song and Xiaobo Du and Yulan Sun and Wei Li and Longhua Sun and Zhiyu Wang and Kunning Yang and Yun Fan and Baogang Liu and Hongyun Zhao and Ying Hu and Li Jia and Shen Xu and Tienan Yi and Dongqing Lv and Haitao Lan and Mengxia Li and Wenhua Liang and Yongsheng Wang and Hui Yang and Yuming Jia and Yuan Chen and Junguo Lu and Meiqi Shi and Chunling Liu and Ming Zhou and Jianya Zhou and Xianling Liu and Ningning Zhou and Ming He and Xiaorong Dong and Hualin Chen and Yongxing Chen and Haichuan Su and Xiaoling Li and Zhihong Zhang and Lei Yang and Ying Liu and Likun Chen and Xue Hou and Yu Zhang and Jun Guo and Ruiqiang Ma and Hong Lu and Di Wu and Weineng Feng and Wen Li and Jianan Huang and Yan Wang and Xia Song and Jiewen Peng and Laiyu Liu and Yubiao Guo and Wenting Li and Mengying Xia and Dongmei Lu and Mingxiu Hu and Zhongmin Maxwell Wang and Baiyong Li and Michelle Y. Xia and Li Zhang},
  year = {2026},
  journal = {JAMA},
  doi = {10.1001/jama.2026.7745},
  url = {https://doi.org/10.1001/jama.2026.7745}
}

RIS

TY  - JOUR
TI  - Bispecific Antibody Ivonescimab Added to Chemotherapy in
                    <i>EGFR</i>
                    -Variant Non–Small Cell Lung Cancer
AU  - Unknown
AU  - Wenfeng Fang
AU  - Yuanyuan Zhao
AU  - Yongzhong Luo
AU  - Runxiang Yang
AU  - Yan Huang
AU  - Zhiyong He
AU  - Hui Zhao
AU  - Mingjun Li
AU  - Kai Li
AU  - Qibin Song
AU  - Xiaobo Du
AU  - Yulan Sun
AU  - Wei Li
AU  - Longhua Sun
AU  - Zhiyu Wang
AU  - Kunning Yang
AU  - Yun Fan
AU  - Baogang Liu
AU  - Hongyun Zhao
AU  - Ying Hu
AU  - Li Jia
AU  - Shen Xu
AU  - Tienan Yi
AU  - Dongqing Lv
AU  - Haitao Lan
AU  - Mengxia Li
AU  - Wenhua Liang
AU  - Yongsheng Wang
AU  - Hui Yang
AU  - Yuming Jia
AU  - Yuan Chen
AU  - Junguo Lu
AU  - Meiqi Shi
AU  - Chunling Liu
AU  - Ming Zhou
AU  - Jianya Zhou
AU  - Xianling Liu
AU  - Ningning Zhou
AU  - Ming He
AU  - Xiaorong Dong
AU  - Hualin Chen
AU  - Yongxing Chen
AU  - Haichuan Su
AU  - Xiaoling Li
AU  - Zhihong Zhang
AU  - Lei Yang
AU  - Ying Liu
AU  - Likun Chen
AU  - Xue Hou
AU  - Yu Zhang
AU  - Jun Guo
AU  - Ruiqiang Ma
AU  - Hong Lu
AU  - Di Wu
AU  - Weineng Feng
AU  - Wen Li
AU  - Jianan Huang
AU  - Yan Wang
AU  - Xia Song
AU  - Jiewen Peng
AU  - Laiyu Liu
AU  - Yubiao Guo
AU  - Wenting Li
AU  - Mengying Xia
AU  - Dongmei Lu
AU  - Mingxiu Hu
AU  - Zhongmin Maxwell Wang
AU  - Baiyong Li
AU  - Michelle Y. Xia
AU  - Li Zhang
PY  - 2026
JO  - JAMA
DO  - 10.1001/jama.2026.7745
UR  - https://doi.org/10.1001/jama.2026.7745
ER  - 

APA

Unknown, Fang, W., Zhao, Y., Luo, Y., Yang, R., Huang, Y., He, Z., Zhao, H., Li, M., Li, K., Song, Q., Du, X., Sun, Y., Li, W., Sun, L., Wang, Z., Yang, K., Fan, Y., Liu, B., Zhao, H., Hu, Y., Jia, L., Xu, S., Yi, T., Lv, D., Lan, H., Li, M., Liang, W., Wang, Y., Yang, H., Jia, Y., Chen, Y., Lu, J., Shi, M., Liu, C., Zhou, M., Zhou, J., Liu, X., Zhou, N., He, M., Dong, X., Chen, H., Chen, Y., Su, H., Li, X., Zhang, Z., Yang, L., Liu, Y., Chen, L., Hou, X., Zhang, Y., Guo, J., Ma, R., Lu, H., Wu, D., Feng, W., Li, W., Huang, J., Wang, Y., Song, X., Peng, J., Liu, L., Guo, Y., Li, W., Xia, M., Lu, D., Hu, M., Wang, Z. M., Li, B., Xia, M. Y., & Zhang, L. (2026). Bispecific Antibody Ivonescimab Added to Chemotherapy in <i>EGFR</i> -Variant Non–Small Cell Lung Cancer. JAMA. https://doi.org/10.1001/jama.2026.7745

Source records